The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fitzsimmons, S. P.
Right arrow Articles by Shapiro, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fitzsimmons, S. P.
Right arrow Articles by Shapiro, M. A.
The Journal of Immunology, 1998, 161: 2290-2300.
Copyright © 1998 by The American Association of Immunologists

Asymmetric Contribution to Ig Repertoire Diversity by V{kappa} Exons: Differences in the Utilization of V{kappa}10 Exons

Sean P. Fitzsimmons, Benjamin T. Rotz and Marjorie A. Shapiro1

Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD 20892


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The mouse has approximately 140 germline V{kappa} genes, and functional V{kappa} exons are expressed at roughly equivalent levels in the preimmune repertoire. We have examined the expression of individual members of the V{kappa}10 family. V{kappa}10A and V{kappa}10B genes have been utilized in numerous hybridomas and myelomas, while V{kappa}10C has not. In this study, we have cloned the V{kappa}10C gene and shown that it is structurally functional, has the expected promoter elements and recombination signal sequences, and that it is capable of recombination. V{kappa}10C mRNA, however, is present at levels at least 1000-fold lower than V{kappa}10A and V{kappa}10B in adult spleens. While there are no sequence differences in the octamer or TATA box between V{kappa}10C and V{kappa}10A, there are three nucleotide changes in the promoter region. These promoters equally drive the expression of a reporter gene in B cells or plasma cells, but the V{kappa}10A promoter is able to drive expression in pre-B cell lines significantly better than the V{kappa}10C promoter (p < 0.05). V{kappa}10C rearrangements can be detected in bone marrow and splenic DNA. Therefore, the lack of V{kappa}10C expression may reflect the inability of V{kappa}10C-rearranged cells to undergo positive or negative selection. Our results suggest that the available Ab repertoire is shaped not only by the number of structurally functional genes, but also by the ability of assembled genes to be expressed at critical points during B cell maturation.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The recombination of an estimated 140 germline V{kappa} genes (1) with multiple J{kappa} genes and 100 to 200 VH (2, 3) genes with multiple DH and JH genes in the mouse confers an enormous potential preimmune repertoire of Ab specificities. Diversity is further enriched by the contributions of junctional additions or deletions of nucleotides, the combinatorial pairing of individual heavy and light chain proteins, and finally, somatic mutation that occurs in the periphery. By these mechanisms it has been estimated that 109 to 1011 distinct Ab specificities are theoretically possible. The primary Ab repertoire is more limited in size because it is shaped by the number of functional V genes in the genome, the frequency of individual V gene recombination, the effect of promoter efficiency on transcription (4, 5, 6), the ability of specific VH and VL chains to pair, and positive or negative selection of B cells during ontogeny (7, 8, 9).

The precise mechanisms governing the selection of individual VH and V{kappa} exons for rearrangement and expression are unclear. Several studies have examined the use of VH or V{kappa} genes at the family level. In some instances, the utilized repertoire was reported to be nonrandom. For example, early in ontogeny, VH gene families that lie proximal to DJ genes are utilized to a greater extent than those distal to DJ (10, 11, 12, 13), while in the adult mouse, VH utilization does not appear to be positionally biased, but correlates with the size of a given family (12, 14, 15, 16, 17, 18). A positional bias is not evident at the {kappa} locus during early development, and furthermore, the frequency of V{kappa} utilization in adult mice is not dependent on family size (19, 20, 21). That approximately 40% of V{kappa} genes lie in an opposite transcriptional orientation relative to J{kappa} and rearrange by inversion (22) may explain some of the observed differences in V{kappa} and VH utilization. As a byproduct of inversional recombination, reciprocal products consisting of the fused VJ recombination signal sequences (RSS)2 and the VJ intervening DNA are retained on the chromosome, allowing secondary recombinations between what were once distant V{kappa} genes with J{kappa} gene segments. Rearrangement at the {kappa} locus does not shut down immediately after VJ recombination and, thus, secondary rearrangements may mask detection of any inherent positional bias in the {kappa} locus.

Several investigators have reported the preferential use of certain V{kappa} families early in ontogeny. Medina and Teale showed that the early {kappa} repertoire is dominated by V{kappa} families that undergo inversion-type rearrangements (23). It was shown that the repertoires of day 18 fetal liver and day 15 fetal omentum were restricted to five and six families, respectively, with a predominant usage of the V{kappa}4,5, V{kappa}9, and V{kappa}10 families, all of which undergo recombination by inversion. Kaushik et al. (19) reported a preference for the V{kappa}1 and V{kappa}9 families in B cell colonies derived from splenic B cells of 6- to 8-day-old neonatal mice. In contrast, Ramsden et al. demonstrated that V{kappa} usage from day 14 and 16 fetal livers represented 14 of the 18 known V{kappa} families (24).

In the preimmune repertoire of B lymphocytes, the precise mechanisms favoring selection of one V{kappa} gene over another for recombination and expression are not known. Several factors, however, are known to be necessary for recombination and transcription of V genes. For example, Ig gene rearrangement has been correlated with DNA hypomethylation and chromatin accessibility (25, 26, 27). Often germline transcripts from V genes (4, 28, 29, 30) or the C region locus (31, 32) are detected. It is not known whether these germline transcripts play a role in locus accessibility or if they are a byproduct of an open chromatin configuration. Expression of a V gene requires a functional RSS and a functional promoter. It has been shown that RSS strengths can directly affect the frequency of recombination (33, 34). In addition, differences in promoters of both VH and V{lambda} genes are known to influence transcription efficiencies (4, 6, 35).

Previous studies have compared levels of expression of different VH or VL families, or have examined the functionality of the promoters or RSS of individual genes. In this study, we have compared the utilization of individual, but closely related, V{kappa} genes and the ability of their regulatory sequences to drive efficient recombination or expression.

Members of the same V{kappa} family share >80% homology at the DNA level (36) and, for the most part, lie close together within the {kappa} locus on chromosome 6 of the mouse. We chose to study the V{kappa}10 family, which is small, containing three members (37), V{kappa}10A,3 V{kappa}10B, and V{kappa}10C; resides in the middle of the {kappa} locus (1); and has been shown to rearrange by inversion (22). V{kappa}10A and V{kappa}10B are utilized in response to a wide variety of T-dependent and T-independent Ags and have been isolated and sequenced from numerous hybridomas and myelomas derived from several inbred mouse strains. The third family member, V{kappa}10C, has not been seen in functional Abs and has been isolated only once as a reciprocal product of an aberrant VJ recombination (22, 38). Since V{kappa}10A and V{kappa}10B are expressed in response to a wide variety of Ags and appear to contribute to early repertoire diversity (20), while V{kappa}10C is not utilized, it was of interest to determine the factors limiting a V{kappa} gene’s contribution to diversity.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Isolation of germline V{kappa}10C gene

The V{kappa}10C germline gene (GenBank accession AF029261) was isolated from a genomic library constructed from BALB/c kidney DNA in the {lambda}dash II vector (Stratagene, La Jolla, CA). Plaques were screened by hybridization with a 32P-labeled 0.9-kb PC3386 EcoRI/HindIII fragment (22) on nitrocellulose. Hybridizing fragments from EcoRI and BamHI digests of positive plaque DNAs were subcloned into pBluescript (Stratagene) for sequencing. Genomic clones were cycle sequenced with primers produced in Core Facility for Biotechnology Resources at the Center for Biologics Evaluation and Research, Food and Drug Adminstration, and a dsDNA cycle sequencing kit (Life Technologies, Gaithersburg, MD).

Primer specificities

Oligonucleotides were synthesized in the Core Facility for Biotechnology Resources facility at the Center for Biologics Evaluation and Research and are listed in Table IGo. All PCR reactions were performed in a DNA thermal cycler 480 (Perkin-Elmer, Norwalk, CT) in 100-µl reactions with 1.5 mM MgCl2, 0.05 mM dNTPs, and 50 pmol of each primer. Specific PCR conditions were determined for the V{kappa}10A, V{kappa}10B, and V{kappa}10C primers in cross-priming experiments using hybridoma 226.1 (39) cDNA (V{kappa}10A), hybridoma H24C2 (40) cDNA (V{kappa}10B), and a V{kappa}10C spleen clone 4C17 (see below) as templates. V{kappa}10A and V{kappa}10B primers were specific for their templates under the following conditions: 95°C, 5 min; 73°C, 2 min/95°C, 1 min (30 cycles); and 73°C, 10 min, 4°C hold. The V{kappa}10C primer was specific under identical conditions, but with an annealing/extension temperature of 74°C. As shown in Figure 1Go, the V{kappa}10C primer differs from V{kappa}10A and V{kappa}10B template by 2 and 4 bases, respectively, V{kappa}10B primer differs from V{kappa}10A and V{kappa}10C template by 2 and 3 bases, respectively, and V{kappa}10A primer differs from V{kappa}10B and V{kappa}10C template by 5 and 6 bases, respectively. The C{kappa} region primers 5'KC and 3'KC were specific for their target under the following conditions: 95°C, 5 min; 65°C, 1 min/72°C, 1 min/95°C, 1 min (30 cycles); and 72°C, 10 min, 4°C hold. PCR products obtained from a BALB/c spleen cDNA with V{kappa}10A, V{kappa}10B, V{kappa}10C, and C{kappa} region primers under specific conditions were cloned into the PCRII vector (Invitrogen, San Diego, CA). Twenty clones each for V{kappa}10A, V{kappa}10B, and V{kappa}10C were cycle sequenced using Sp6 and T7 primers under the following conditions: 95°C, 3 min; 55°C, 30 s/70°C, 30 s/95°C, 30 s (20 cycles); and 58°C, 1 min/95°C, 30 s (10 cycles), 4°C hold. Clones A5, 4B16, 4C17, and K7 were used as standards in V{kappa}10A, V{kappa}10B, V{kappa}10C, and C{kappa} semiquantitation assays, respectively.


View this table:
[in this window]
[in a new window]
 
Table I. PCR primers1

 


View larger version (53K):
[in this window]
[in a new window]
 
FIGURE 1. Alignment of V{kappa}10 germline sequences. V{kappa}10A and V{kappa}10B sequences were obtained from GenBank (42). The V{kappa}10C germline sequence was obtained from a BALB/c kidney genomic clone (GenBank accession no. AF029261). Regulatory regions within the promoter are underlined. Proceeding in the 5' to 3' direction, starting within framework 1, the underlined primers are Gen7, V{kappa}10B, V{kappa}10C, V{kappa}10A, and A3. Nucleotide substitutions in the V{kappa}10A and V{kappa}10B germline that result in amino acid changes are in bold type. Gaps resulting from alignment are depicted by dots (.). Splice sites are represented by forward slashes (/).

 
Semiquantitation of V{kappa}10 and total {kappa} mRNA

Total RNA from four BALB/c spleens was isolated using the Trizol method (Life Technologies), according to the manufacturer’s instructions. RNA was reverse transcribed with oligo(dT) primer and the superscript preamplification system (Life Technologies), according to the manufacturer’s instructions. A total of 1 µl of the cDNAs and 1 µl of log dilutions of A5, 4B16, 4C17, and K7 standards (10-1-10-8 for A5, 4B16, and 4C17; 10-1-10-10 for K7) was amplified using the specific PCR conditions described above. {kappa} constant 3'KC primer was the 3' primer for all PCRs, while V{kappa}10A, V{kappa}10B, and total {kappa} PCRs utilized V{kappa}10A-specific, V{kappa}10B-specific, and {kappa} constant 5'KC as 5' primers, respectively. Thirty-five-microliter samples from each reaction tube were electrophoresed in 3% agarose gels at 170 V in 1x TAE for 3 to 4 h. Gels were stained with ethidium bromide (0.5 µg/ml) in 1x TAE for 30 min, and band intensities were quantitated on a fluorimeter. Band intensities of standards were plotted versus number of standard molecules at each dilution. The number of target structures in each cDNA sample was estimated by interpolating its band intensity into the standard curve. V{kappa}10C PCR sensitivity was determined by performing V{kappa}10C PCRs on serially diluted 4C17 standard.

Nested PCRs were performed as described above, with the following exceptions: the 3'KC and Gen7 primers were used to amplify 1 µl of cDNA in the primary PCR, as follows: 95°C, 5 min; 55°C, 1 min/72°C, 1 min/95°C, 1 min (30 cycles). Primary PCR products were purified with Wizard PCR preps columns (Promega, Madison, WI), and 1 µl was used as the template for a secondary PCR with the V{kappa}10A-, B-, and C-specific primers, and the 3'KC2 primer under the cycling conditions described for V{kappa}10A, B, and C PCRs above.

pGL3 {kappa} enhancer/promoter reporter vector construction

Volumes for all PCR reactions were 100 µl with 1.5 mM MgCl2, 0.05 mM dNTPs, and 50 pmol each primer. The V{kappa}10AS (142-bp) promoter fragment was PCR amplified from a BALB/c liver DNA V{kappa}10A genomic clone (22) with the 5'AJ1/10C short HindIII and AJ13' HindIII primers. The V{kappa}10CS (142-bp) promoter fragment was PCR amplified from the {lambda}dash II (Stratagene) BALB/c kidney DNA V{kappa}10C genomic clone 91-3 with the 5'AJ1/10C short HindIII and 10C3'HindIII primers. The intronic {kappa} enhancer (537 bp) was PCR amplified from pECK DNA (containing the intronic {kappa} enhancer and germline {kappa} constant DNA) with the Enhanc.5'KpnI+Enhanc.3'KpnI primers. V{kappa}10AS, V{kappa}10CS, and {kappa} enhancer PCRs were performed, as follows: 95°C, 5 min; 50°C, 1 min/72°C, 1 min/95°C, 1 min (30 cycles); and 72°C, 10 min, 4°C hold. V{kappa}10AS and V{kappa}10CS PCR products were digested with HindIII, and {kappa} enhancer product was digested with KpnI. The {kappa} enhancer fragment was ligated into KpnI-linearized pGL3 basic vector (Promega) and labeled pGL3-{kappa}en. Digested, purified V{kappa}10AS and V{kappa}10CS promoter fragments were ligated into pGL3-{kappa}en linearized with HindIII. Orientation and promoter sequence confirmation were determined by sequencing. Plasmids, including control vector pCMV-ß (Clontech, Palo Alto, CA), were purified by double banding in CsCl.

Transfections and lysate production

All electroporations were performed using a Bio-Rad (Richmond, CA) gene pulser (0.22 kV, 960 µFd) and 0.2-cm path-length cuvettes containing 6 x 106 cells in 250 µl electroporation media (RPMI 1640, 10% FCS, 100 U/ml penicillin, 100 µg/ml streptomycin, nonessential amino acids 1x final concentration, 50 µM 2-ME, and 2 mM glutamine). pCMVß (0.32 µg) was cotransfected with either 5 pmol of pGL3-{kappa}en/V{kappa}10AS, pGL3-{kappa}en/V{kappa}10CS, or pGL3{kappa}en-only into the pre-B cell lines 18-81 and NFS-467, the immature B cell line Wehi 231.4, and the plasmacytoma cell line Sp2/0. The pre-B cell lines NFS-5 and 70Z/3 were each cotransfected with 10 pmol of the promoter plasmids and pGL3-{kappa}en plasmids and 0.32 µg of pCMV-ß as a control. The mature B cell line A20 was cotransfected with 0.5 pmol pGL3-{kappa}en/V{kappa}10AS, pGL3-{kappa}en/V{kappa}10CS, or pGL3-{kappa}en-only, and 1.7 µg pCMV-ß. Following transfection, cells were transferred to T75 flasks containing 15 ml complete RPMI and incubated for 24 h at 37°C in 5% CO2. After 24 h, cells were harvested by centrifugation, washed once in PBS, and lysed for 15 min in 70 µl 1x reporter lysis buffer (Promega). Cellular debris was pelleted by centrifugation at 11,000 rpm for 2 min at 4°C. Supernatants were transferred to new tubes and stored at -70°C.

Luciferase and ß-galactosidase assays

For luciferase assays, 20 µl of lysate was combined with 100 µl of luciferase assay substrate (Promega) in the wells of a microlite I 96-well tray (Dynatech, Chantilly, VA), and light production was measured in a luminometer. For ß-galactosidase assays, 5 µl of lysate was added to the wells of a microlite I 96-well tray and combined with 50 µl of galacton plus (Tropix, Bedford, MA) diluted 1/100 in 0.1 M sodium phosphate, pH 7, and incubated for 15 min at room temperature. A total of 50 µl of emerald enhancer (Tropix) diluted 1/10 in 0.2 N NaOH was added to each well, and light production was measured in a luminometer. Luciferase activity was calculated by dividing the luciferase luminometer value by the ß-galactosidase value for each well. Statistical differences in V{kappa}10 promoter efficiencies were analyzed using one-way ANOVA.

V{kappa}10 DNA recombination

BALB/c genomic DNAs (100 ng) from spleen and ThB-enriched bone marrow B cells (see below) were amplified with the Gen7 and J{kappa} 5–3 primer pair to amplify all V{kappa}10 rearrangements. PCRs were performed in duplicate 100-µl reactions (pooled before gel loading) with 1.5 mM MgCl2, 0.05 mM dNTPs, and 50 pmol each primer under the following conditions: 95°C, 5 min; 60°C, 1 min/72°C, 2 min/95°C, 1 min (30 cycles); and 72°C, 10 min, 4°C hold. Thirty-seven microliters of each sample were electrophoresed on triplicate 2.3% agarose gels for 3 h at 150 V. Included on each gel as specificity controls were genomic clones for V{kappa}10A (2.1-kb EcoRI/BamHI fragment from pC13-13 (22)) and V{kappa}10C (2.4-kb EcoRI fragment from the pBluescipt 91-3), and an RT-PCR clone for V{kappa}10B (4B16 EcoRI digest). EcoRI digests of RT-PCR clones A5 and 4C17 were included on the V{kappa}10A and V{kappa}10C gels, respectively, as additional positive controls. EcoRI-digested 4B16 was used as both the specificity and positive control on the V{kappa}10B gel, since a genomic clone of V{kappa}10B was not available. DNA was transferred to positively charged nylon membranes in 10x SSC overnight by capillary action, and UV cross-linked to filters in a Bio-Rad gene linker (150 mJ). Oligonucleotide labeling and washing methods were described by Pennycook et al. (41). Membranes were prehybridized in separate roller tubes with 20 ml 5x SSC, 2.5% skim milk powder, 0.1% N-laurylsarcosine, and 0.02% SDS at 42°C for 4 h. Oligonucleotides V{kappa}10A3, V{kappa}10B, and V{kappa}10C were end labeled with [{gamma}-32P]dATP and purified on Select-D G25 spin columns (5 prime->3 prime, Boulder, CO). A quantity amounting to 3 x 107 total cpm of either the V{kappa}10A3, V{kappa}10B, or V{kappa}10C probe was added to the tubes containing the prehybridization solution and hybridized overnight at 42°C. Blots were washed twice for 5 min with 2x SSC, 0.1% SDS at room temperature and twice for 15 min at 42°C (V{kappa}10A3), 51°C (V{kappa}10B), or 57°C (V{kappa}10C). The V{kappa}10C primer differs from V{kappa}10A and V{kappa}10B template by 2 and 4 bases, respectively, V{kappa}10B primer differs from V{kappa}10A and V{kappa}10C template by 2 and 3 bases, respectively, and V{kappa}10A3 primer differs from V{kappa}10B and V{kappa}10C template by 7 bases. The specificity of each probe was determined experimentally by washing nylon strips containing the V{kappa}10A and V{kappa}10C genomic clones and the V{kappa}10B RT-PCR clone 4B16 at increasing temperatures until each probe hybridized to its own V{kappa}10 family member and not the other two. Membranes were placed in Molecular Dynamics (Sunnyvale, CA) PhosphorImager cassettes overnight. Screens were developed using a Molecular Dynamics PhosphorImager and Image Quant software.

ThB enrichment of bone marrow B cells

Bone marrow cells collected from both femurs and tibiae were resuspended at 1 to 4 x 107 cells/ml PBS and incubated with biotin-labeled anti-ThB at 4°C with gentle shaking for 30 min. Cells were washed twice in HBSS, pH 7.4, and mixed with Dynabeads M-280 streptavidin at a ratio of 4:1 beads/cell, with the beads at 1 to 2 x 107 beads/ml. Cells and beads were incubated at 4°C with rotation for 30 min. The cells bound to the beads were collected with a Dynal (Great Neck, NY) MPC-1 or MPC-2 magnet. Genomic DNA was prepared from the ThB+-selected population. Flow-cytometric analysis of cells before enrichment showed ThB+ cells ranging from 12 to 24% of total bone marrow cells. After enrichment, 4 to 5% of unselected cells were ThB+ (data not shown).


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Isolation and sequencing of V{kappa}10C germline gene

The V{kappa}10 family contains three members (37). Southern blots of BALB/c BamHI-digested or EcoRI-digested kidney genomic DNA with a 0.9-kb PC3386 probe labeled with 32P revealed two and three strongly hybridizing bands, respectively (data not shown and (37)). The smaller (5.2-kb) BamHI band is a doublet that is known to contain both V{kappa}10A and V{kappa}10B. The V{kappa}10A gene resides on a 5.2-kb EcoRI fragment, while the V{kappa}10B gene resides on a 3.7-kb EcoRI fragment (42). Although unconfirmed, the 7.4-kb BamHI and the 2.6-kb EcoRI bands most likely contain the V{kappa}10C gene.

The V{kappa}10C germline gene was isolated from a BALB/c kidney genomic library and sequenced beginning from ~600 bp 5' of the transcription start site to 1700 bp 3' of the heptamer/nonamer. Analysis of the V{kappa}10C sequence (Fig. 1Go) shows it is structurally functional. There are no obvious defects such as frameshifts or missense mutations to easily explain the lack of detection of V{kappa}10C in functional Abs. Comparison of the germline sequence of V{kappa}10C with germline V{kappa}10A and V{kappa}10B sequences reveals that it is most closely related to V{kappa}10B, sharing 97% homology in the coding region and 94% homology with V{kappa}10A. The majority of base substitutions among the V{kappa}10 family members occur in the CDRs. The promoter region, splice site, and RSS of V{kappa}10C are also intact. V{kappa}10C differs from V{kappa}10A in the last position of the nonamer; however, this difference is shared with V{kappa}10B, which is known to be expressed, and most likely does not account for a decrease in recombination efficiency.

The V{kappa}10C amino acid sequence (Fig. 2Go) is 91 and 94% homologous to V{kappa}10A and V{kappa}10B, respectively, differing primarily in the CDRs. The V{kappa}10C sequence contains two unusual substitutions: a Cys to Tyr substitution at position -1 of the leader peptide, and a Thr to Ala substitution at position 69 in framework 3. Neither of these substitutions is thought to interfere with light chain processing, folding, or the ability to pair with heavy chain (see Discussion).



View larger version (34K):
[in this window]
[in a new window]
 
FIGURE 2. Translation of V{kappa}10 germline genes. V{kappa}10A and V{kappa}10B sequences were obtained from GenBank, V{kappa}10C was translated from the germline sequence.

 
Semiquantitation of spleen V{kappa}10 mRNA

A search of DNA databases revealed that both V{kappa}10A and V{kappa}10B light chains are utilized in response to a wide variety of T-dependent and T-independent Ags in different inbred mouse strains, while V{kappa}10C has not yet been detected in a functional Ab. We wanted to determine whether this was due to the lack of appropriate Ags selecting for V{kappa}10C or if V{kappa}10C is underexpressed in the spleen. It has been estimated in murine spleen that individual V{kappa} exons represent approximately 0.6% of total {kappa} mRNA (43).

RT-PCR experiments to detect the presence of V{kappa}10A, B, and C message in an adult BALB/c mouse were performed with the 5' V{kappa}10A, B, and C primers shown in Figure 1Go and Table IGo and a 3' primer (3'KC) from the C{kappa} region (Table IGo). Specific conditions were determined in cross-priming experiments in which cDNA from both V{kappa}10A (226.1)- and V{kappa}10B (H24C2)-producing hybridomas was amplified with the three gene-specific V{kappa}10 primers and the C{kappa} region primer 3'KC (data not shown). Using specific conditions established in the hybridoma cross-priming experiments, we were able to detect V{kappa}10A, B, and C mRNA in the spleen of an adult mouse (Fig. 3Go). V{kappa}10A and V{kappa}10B appeared as intense bands, while V{kappa}10C was barely visible. This was the only mouse tested that had visible V{kappa}10C bands after a single PCR (see below). The RNA from this mouse was consumed during assay development and was not quantitated. Nineteen clones each of V{kappa}10A, V{kappa}10B, and V{kappa}10C RT-PCR products were sequenced to establish the specificity of each reaction (data not shown). Mispriming events were not observed.



View larger version (79K):
[in this window]
[in a new window]
 
FIGURE 3. V{kappa}10 RT-PCR of BALB/c spleen. A total of 5 µg of splenic RNA was reverse transcribed, and 2 µl of cDNA was used as template for PCR with the V{kappa}10-specific primers and the C{kappa} region primer 3'KC under conditions specific for each gene (see Materials and Methods).

 
The levels of V{kappa}10A, B, and C mRNA in the spleens of four adult BALB/c mice were measured semiquantitatively using cloned V{kappa}10 products from adult spleen RT-PCRs to construct standard curves. Total {kappa} mRNA levels were determined similarly using a standard curve for the C{kappa} region. The concentration of each mRNA product was calculated by interpolation of the intensity of each sample band into the curve (Fig. 4Go). Three mice tested were 3 mo of age, while a fourth mouse was 14 mo of age. Figure 5Go shows that V{kappa}10A and B are expressed at equivalent levels in the 3-mo-old mice and represent from 0.3 to 3.4% of total {kappa} message, which is consistent with the estimate that individual V{kappa} genes are expressed at a frequency of 0.6% in preimmune B cells (43). While no statistically significant difference between the levels of V{kappa}10A and V{kappa}10B mRNA was observed in the 3-mo-old mice, the 14-mo-old mouse (mouse 4) had significantly lower levels of V{kappa}10B compared with V{kappa}10A (p < 0.05). In all four mice tested, the level of V{kappa}10C mRNA was below the detection limit (1.14 x 103 targets) of the assay. As is common in a PCR-based quantitative assay, variations in the levels of V{kappa}10A, V{kappa}10B, and total {kappa} were evident for all mice tested. However, compared with the average level of expression for V{kappa}10A and B mRNA derived from multiple assays and, based on the sensitivity of the V{kappa}10 PCR, we estimate that V{kappa}10C mRNA is present at least 1000-fold less than that of V{kappa}10A and V{kappa}10B in the 3-mo-old mice. In the 14-mo-old mouse, V{kappa}10C is present at approximately 1000-fold less than V{kappa}10A, and 10- to 100-fold less than V{kappa}10B. Splenic B cells were stimulated with LPS to expand underrepresented clones, and V{kappa}10C message was still undetectable by RT-PCR. V{kappa}10C message could be detected by a nested PCR from the spleen of a 3-mo-old mouse, indicating that V{kappa}10C mRNA is present at low levels (data not shown).



View larger version (53K):
[in this window]
[in a new window]
 
FIGURE 4. Semiquantitative V{kappa}10A RT-PCR. A, representative semiquantitative RT-PCR of V{kappa}10A message from BALB/c spleens. A total of 1 µl of cDNA and 1 µl of diluted A5 standards was amplified with the V{kappa}10A and 3'KS primer, as described in Materials and Methods. Thirty-five microliters of each sample and standard were electrophoresed in a 3% gel and stained with ethidium bromide. B, Band intensities from the A5 standards in the gel shown in A were measured in a fluorimeter and plotted versus the number of standard molecules calculated at each dilution. Band intensities for the four samples were interpolated into the A5 standard curve to calculate the number of V{kappa}10A target structures in the cDNA. Similar experiments were performed to measure V{kappa}10B. V{kappa}10C was not detectable by this method, and was thus deemed to be present at or below the detection limit of the assay (approximately 1100 target structures).

 


View larger version (24K):
[in this window]
[in a new window]
 
FIGURE 5. V{kappa}10 and total {kappa} semiquantitative RT-PCRs from BALB/c spleens. Summary graph of V{kappa}10 and total {kappa} semiquantitative RT-PCRs from BALB/c spleens. For each mouse, the V{kappa}10A, V{kappa}10B, and total {kappa} quantitations were determined from the same cDNA preparation in multiple assays. The V{kappa}10C data shown represent experiments from all four mice.

 
V{kappa}10 expression in bone marrow and fetal liver

It has been shown that V{kappa}10 genes contribute substantially to the repertoire in early B cell development and that the V{kappa}10 sequences detected in fetal liver, fetal omentum, and bone marrow all derived from the V{kappa}10A or V{kappa}10B genes (23, 24). Our examination of the expression of V{kappa}10 genes in bone marrow and fetal liver revealed that V{kappa}10A mRNA was readily detectable using a single RT-PCR reaction in both adult bone marrow and fetal livers. In fetal liver, V{kappa}10A was detectable as a faint band at day 16 and increased in intensity through day 19 (data not shown). Neither V{kappa}10B nor V{kappa}10C was detectable using a single RT-PCR reaction in either tissue. Using a nested PCR reaction, both V{kappa}10B and V{kappa}10C mRNAs could be detected in the bone marrow, and by day 18 in fetal livers (data not shown).

Comparison of V{kappa}10A and V{kappa}10C promoter efficiency

Since V{kappa}10C is poorly expressed in splenic B cells, we next compared the V{kappa}10C promoter efficiency with that of V{kappa}10A. The major elements of a V{kappa} gene promoter are the octamer (44, 45) and a TATA box. These elements are contained within a ~70- to 100-bp region that has been defined as the minimal promoter necessary for driving {kappa} transcription (44, 46, 47). A comparison of the V{kappa}10A and V{kappa}10C gene promoters is shown in Figure 6GoA. Both promoters contain identical octamers that differ from the consensus octamer by 2 bases. Neither V{kappa}10A nor V{kappa}10C contain a consensus TATA box, but both genes have the sequence TAATT at position -27. V{kappa}10A and V{kappa}10C also contain the pentadecamer and {kappa}Y sites, which have also been implicated in activation of {kappa} transcription (44, 48). The pentadecamers for both genes are identical, lie upstream of the octamer, and differ from the consensus pentadecamer by a single base (TGCAGCTGTGCTCAG). The {kappa}Y site, unlike those reported by Atchison (48), is downstream of the octamer and differs from the consensus by 2 bases (CTTCCTAT). Overall, the 142-bp V{kappa}10A promoter differs from that of V{kappa}10C at three positions, an A to C substitution at position -6, a C to G substitution at position -42, and an additional A nucleotide at position -97 just upstream of the octamer. Two of these substitutions, the C to G at position -42 and the A to C at position -6, lie within a potential transcription-regulatory element (CANNTG), the E-box (49, 50). At position -42, the V{kappa}10A E-box sequence (CAGATT) differs from the V{kappa}10C sequence by a single base (CACATT). In the downstream E-box beginning at position -10, both V{kappa}10A (CAGCCTG) and V{kappa}10C (CAGCATG) contain unique insertions into an E-box sequence.



View larger version (34K):
[in this window]
[in a new window]
 
FIGURE 6. V{kappa}10A and V{kappa}10C promoter alignments and efficiencies in B cells of different lineages. A, V{kappa}10C and V{kappa}10A promoters were made by PCR (see Materials and Methods) and cloned into the PGL3 luciferase reporter vector containing the {kappa} intronic enhancer. Known regulatory sequences are in bold. PGL3{kappa}enAS, PGL3{kappa}enCS, and PGL3{kappa}en without insert were cotransfected into B, immature B cells (Wehi 231.4), mature B cells (A20), and the plasmacytoma line Sp2/0, and C, pre-B cells with the control vector pCMV-ß. Each transfection was repeated six times. Luciferase expression was assayed after 24 h, and differences in V{kappa}10A and V{kappa}10C promoter-driven expression of luciferase were compared by one-way ANOVA.

 
The 142-bp promoters of V{kappa}10A and V{kappa}10C shown in Figure 6GoA were cloned into pGL3{kappa}en (the pGL3 luciferase reporter vector containing the {kappa} intronic enhancer). These promoter clones or pGL3{kappa}en as a control were used to transfect B cell lines representing the pre-B cell, immature B cell, mature B cell, and plasma cell stages of B cell development. The pre-B cell lines used were 18-81, 70Z/3, NFS-5, and NFS-467. Other cell lines examined include the immature B cell line Wehi 231.4, the mature B cell line A20, and the plasmacytoma cell line Sp2/0. All cells were cotransfected with pCMV-ß for normalization purposes. V{kappa}10A and V{kappa}10C promoter activity in Wehi 231.4, A20, and SP2/0 was not significantly different (Fig. 6GoB). In all of the pre-B cell lines tested, the V{kappa}10A promoter construct significantly outperformed that of V{kappa}10C (Fig. 6GoC) (p < 0.05, one-way ANOVA). Constructs containing longer promoters of 300 and 500 bp from V{kappa}10A and V{kappa}10C were also tested and yielded similar results (data not shown). Three of these pre-B cell lines have active Ig loci: 18-81 undergoes VDJ recombination in vitro, but its {kappa} locus is silent (51); 70Z/3 contains an unexpressed, but rearranged, {kappa} locus that can be induced by stimulation with LPS (52); and in NFS-5, both {kappa}- and {lambda}-expressing clones can be purified from the bulk culture, and the rearranged VH gene has been shown to undergo VH gene replacement (53, 54). NFS-467 has not been examined for the ability of its Ig loci to rearrange in culture.

V{kappa}10-J{kappa} recombination

The RSS of V{kappa}10A and V{kappa}10C differ at the last position of the nonamer, a T to G substitution. The V{kappa}10B and V{kappa}10C RSS, however, are identical, and V{kappa}10B mRNA is present at similar levels as V{kappa}10A in adult spleen, suggesting that the RSS difference between V{kappa}10A and V{kappa}10B/C does not influence the efficiency of V{kappa}10C recombination. While the efficiency of the V{kappa}10C RSS is likely to be equivalent to that of V{kappa}10A and V{kappa}10B, we do not know whether the frequency of V{kappa}10C recombination is also equivalent. To examine this question, PCR was performed on genomic DNA using a 5' probe and an annealing temperature that would amplify all three family members, and a 3' probe lying downstream of J{kappa}5. Thus, all amplified rearrangements would be in the context of the C{kappa} region and not as a part of a reciprocal joint to a VJ recombination. We examined DNA isolated from both spleen and ThB-enriched bone marrow cells. ThB is a differentiation Ag expressed on thymocytes and on B cells, with its expression first seen on pre-B cells, the differentiation stage at which light chain rearrangement begins (55, 56). Thus, enriching for ThB-expressing cells would capture all B-lineage cells in the bone marrow undergoing the transition to or already having made the transition to an immature B cell.

V{kappa}10 recombination products were hybridized with 32P-labeled V{kappa}10A3, V{kappa}10B, and V{kappa}10C oligonucleotide probes. Recombinations to all four J{kappa} genes were detectable for all V{kappa}10 family members in both ThB-enriched bone marrow and spleen (Fig. 7Go). This assay is not quantitative, and the less intense V{kappa}10C bands most likely result from the higher wash temperature needed for specificity of the V{kappa}10C probe. In preliminary experiments done for probe specificity, specific band intensities (for all probes) were shown to decrease as wash temperatures were elevated (data not shown). Additionally, although the V{kappa}10 PCR annealing temperature was adjusted to amplify all V{kappa}10 products, the Gen7 primer differs from V{kappa}10C by a single base and may influence yield of V{kappa}10C products. Because V{kappa}10C recombinations are detected in both tissues, these data suggest that most V{kappa}10C-rearranged cells do not undergo negative selection and elimination in the bone marrow. It is not known whether these V{kappa}10C rearrangements are productive or nonproductive.



View larger version (57K):
[in this window]
[in a new window]
 
FIGURE 7. V{kappa}10 recombination products. A, V{kappa}10-J{kappa} recombination products from BALB/c spleen and ThB-enriched bone marrow genomic DNAs were PCR amplified and blotted with 32P-labeled V{kappa}10A3, V{kappa}10B, or V{kappa}10C oligonucleotides, as described in Materials and Methods. Shown are representative results from one of three mice. Blots were washed at the indicated temperatures 2 x 15 min in 2times] SSC/0.1% SDS. B, Positive and specificity controls for V{kappa}10A, B, and C were included on each PCR gel and blotted and washed, as described above.

 
Sequence analysis of V{kappa}10A and V{kappa}10C PCR clones

We analyzed the translated sequences of cloned V{kappa}10A and V{kappa}10C RT-PCR products derived from the initial control assays. Nineteen sequences for each gene were analyzed. Of these 19 sequences, 10 of 19 V{kappa}10A and 13 of 19 V{kappa}10C sequences were established as unique based on their nucleotide sequences.

Of the 10 V{kappa}10A rearrangements, 7 recombined with J{kappa}1, and 3 with J{kappa}2 (Table IIGo). Three of these rearrangements were nonproductive due to out-of-frame rearrangements (2 involving J{kappa}1, and 1 with J{kappa}2). Of the 13 V{kappa}10C sequences examined, 9 were to J{kappa}1, 2 to J{kappa}4, and 1 each to J{kappa}2 and J{kappa}5 (Table IIGo). As with V{kappa}10A, three of the V{kappa}10C rearrangements were also nonproductive due to out-of-frame rearrangements (2 to J{kappa} 1, and 1 to J{kappa}4 rearrangement).


View this table:
[in this window]
[in a new window]
 
Table II. Cloned V{kappa}10 junctions1

 
An interesting observation of the remaining seven V{kappa}10C sequences rearranged to J{kappa}1 is that five lack the proline at position 95. Proline 95 is an invariant residue. In each of these clones, leucine, the penultimate amino acid of the three V{kappa}10 coding regions, is the amino acid immediately preceding the J{kappa} region. Proline 95 is seen in all of the functional V{kappa}10A junctions examined and in all V{kappa}10A and V{kappa}10B sequences selected from the protein database. It is possible that the loss of this invariant residue from the V{kappa}-J{kappa} junction in V{kappa}10C rearrangements leads to improper folding of the V{kappa}10C light chain or impedes its ability to pair with heavy chain, effectively resulting in nonproductive rearrangements.

V{kappa}10A and V{kappa}10C harbor LINE elements downstream of the coding region

V{kappa}10 gene segments, as well as up to 40% of all V{kappa} genes, lie in opposite transcriptional orientation relative to the J{kappa} locus and rearrange by inversion (22). Recombination by inversion results in the formation of reciprocal products that are retained on the chromosome. The V{kappa}10 family and other families that rearrange by inversion, such as V{kappa}4, V{kappa}8, and V{kappa}12,13, contain a conserved BamHI site approximately 1 kb downstream of the coding region (22, 57, 58). Rearrangement of one of these genes with J{kappa}1 results in an 8-kb BamHI reciprocal product. An analysis of splenic DNA for 8-kb BamHI reciprocal products resulted in an estimate that approximately 25% of V{kappa} alleles retain this BamHI site. Since this site is conserved downstream of many different V{kappa} genes, it has been postulated that this site may play a role in regulation of V{kappa} rearrangement (57). Sequences >=1 kb downstream from the germline V{kappa}10A and V{kappa}10C genes and a germline V{kappa}8 gene were determined. Both V{kappa}10A and V{kappa}8 germline sequences contain the 1-kb BamHI site, whereas the V{kappa}10C sequence does not. It is known from the restriction maps of other investigators (42) that the V{kappa}10B germline gene also has a 3' BamHI site. The BamHI sites for V{kappa}10A and V{kappa}8 are contributed by LINE elements (59) that lie in an inverted orientation 600 and 850 bp downstream of the V{kappa}10A and V{kappa}8 coding regions, respectively. The LINEs are truncated at different points in their respective 3' regions, but both contain the BamHI site at position 6989 of the LINE sequence. Like V{kappa}10A, V{kappa}10C harbors a LINE element 600 bp downstream of the coding region, but the region containing the BamHI site at position 6989 is absent due to a truncation at position 5690 of the LINE sequence.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Previous studies examining the generation of Ab diversity have compared the expression of different VH or VL families (10, 11, 12, 14, 15, 16, 17, 18). Others have looked at promoters or RSS of individual genes and identified differences that lead to more or less efficient transcription (4, 6, 35) or recombination (60). Recently, Buchanan et al. compared the promoters of VH families and showed that there may be differential transcription and regulation of VH promoters in vivo (35). In this study, we have examined and compared both the promoters and RSS of individual members of one V{kappa} family. This study demonstrates that a structurally functional V{kappa} gene, with no apparent defect in its promoter sequence or RSS, is underutilized in both the emerging and adult repertoires.

The V{kappa}10 family contains three members, V{kappa}10A and V{kappa}10B, whose sequences have been previously published (42, 61), and V{kappa}10C, whose sequence is reported in this work. It was of interest to study this family because V{kappa}10A and V{kappa}10B are utilized by a variety of inbred strains in response to a diverse array of Ags, including T dependent, T independent, and autoantigens, while V{kappa}10C has not been detected in a functional Ab. All of the V{kappa}10 sequences in the GenBank database could be assigned to either the V{kappa}10A or V{kappa}10B genes. Indeed, a V{kappa}10C sequence has only been reported once, as part of a reciprocal element to a VJ join that has undergone a V{kappa}10C to J{kappa}1 rearrangement (22).

The V{kappa}10C gene is structurally intact and does not contain stop codons, deletions, or insertions that might explain its underrepresentation in splenic B cells. It is >=94% homologous at the nucleic acid level and >=90% at the amino acid level with V{kappa}10A and V{kappa}10B. The V{kappa}10C promoter, splice sites, and RSS are intact. V{kappa}10C contains a rare Thr to Ala substitution at position 69 in framework 3. Threonine is highly conserved at this position, but an Ala residue has been detected at this position in a V{kappa}10A sequence (62), and is therefore not believed to impede light chain folding or pairing with heavy chain. Another rare substitution in V{kappa}10C is Cys to Tyr at position -1 of the leader peptide. Leader peptides are variable at this position (63), and one human light chain signal peptide is known to contain a Tyr at position -1 (64). Therefore, the Cys to Tyr substitution at position -1 of the leader peptide is unlikely to interfere with light chain processing.

We have shown that V{kappa}10A and V{kappa}10B are transcribed at equivalent levels in adult spleen, while V{kappa}10C is present at levels at least 1000-fold lower. V{kappa}10A mRNA was readily detectable in day 16 to 19 fetal livers and in bone marrow. V{kappa}10B and V{kappa}10C were only detectable in day 18 to 19 fetal livers and bone marrow using a nested PCR, indicating that both V{kappa}10B and V{kappa}10C mRNAs are present at significantly lower levels than V{kappa}10A in early development. Clones expressing V{kappa}10B may be expanded in the spleen in response to environmental Ags. Low levels of V{kappa}10C mRNA in spleen may be due to the lack of a suitable environmental stimulus to expand V{kappa}10C-expressing clones. We observed no increase, however, in V{kappa}10C mRNA levels after stimulation of splenic B cells with LPS.

To further examine the low levels of V{kappa}10C mRNA expression, the sequences of the V{kappa}10A and C promoters and their ability to drive expression of reporter constructs were compared. V{kappa} promoters contain several motifs that have been demonstrated to play a role in transcription. The most important of these sequences is the octamer (44, 45) element to which bind the Oct-1 and Oct-2 proteins. Other regulatory elements of the {kappa} promoter include the {kappa}Y site, which has been shown to lie upstream of the octamer and can compensate for a mutated octamer in a V{kappa}19 gene (48), and the pentadecamer (44), which is highly conserved among V{kappa} promoters. E-boxes, originally described by Ephrussi (49), are contained within the pentadecamer sequence (44) and function as promoter elements. Evidence that these sites can function as promoter elements was provided by Hogbom et al. (50), who demonstrated that a range of nuclear proteins bound to the SP6 {kappa} promoter pentadecamer. Interestingly, these sites had variable efficiency as promoter elements depending on the cells/cell lines used in the experiments.

A comparison of the V{kappa}10A and C promoter sequences shows there are no differences between V{kappa}10A and C in the major promoter elements, the octamer, pentadecamer, {kappa}Y site, and TATA box (Fig. 6GoA). V{kappa}10A and V{kappa}10C promoters each contain one E-box motif within the pentadecamer and two potential E-boxes downstream of the octamer. There are three nucleotide differences between the V{kappa}10A and C promoters. At position -97, the V{kappa}10C promoter contains a string of four As immediately upstream of the octamer, while the V{kappa}10A promoter contains five A nucleotides. Baumruker et al. (65) have shown that octamer-flanking sequences can alter the affinity of Oct-1 binding to the VH octamer. Likewise, Sigvardsson et al. (66) have shown that 3' flanking sequences of the SP6 {kappa} promoter can affect the affinity of Oct-2A binding to the octamer. The other differences are in two potential E-box sites at positions -42 and -6. At position -42, the V{kappa}10A (CAGATT) and V{kappa}10C (CACATT) E-box sequences differ by a single base. At position -6, V{kappa}10A and V{kappa}10C each have a unique insertion into the E-box sequence.

To determine whether differences in the V{kappa}10A and V{kappa}10C promoters could explain the difference in mRNA levels between these genes, we examined the V{kappa}10A and V{kappa}10C promoter efficiencies in transiently transfected B cell lines representing different developmental stages. While the V{kappa}10C promoters worked as efficiently as V{kappa}10A promoters in immature B cells, mature B cells, and plasma cells, a statistically significant difference was observed in pre-B cells (Fig. 6GoC). This phenomenon was seen in all four pre-B cell lines tested. The biologic significance of this difference is unclear. It is possible that a complex of pre-B cell nuclear transcription factors binds with less affinity to the V{kappa}10C promoter due to one or all of the three nucleotide changes in this promoter, resulting in lower levels of V{kappa}10C transcripts. Experiments are in progress to address this question. The late pre-B cell stage in development is when light chain rearrangement begins. If the V{kappa}10C promoter is inefficient in pre-B cells, one possibility might be that insufficient amounts of V{kappa}10C protein are produced at this critical point in the B cell developmental pathway to express surface IgM. In such a scenario, this cell could undergo further light chain recombination, receptor editing, or be eliminated by apoptosis.

We next examined the ability of the V{kappa}10C gene to rearrange. The V{kappa}10C RSS differs from that of V{kappa}10A by one nucleotide, the terminal base in the nonamer. This position has not been shown to affect recombination efficiency. Since V{kappa}10C and V{kappa}10B have identical RSS, this change is not likely to be responsible for the underutilization of the V{kappa}10C gene. Indeed, we demonstrated that V{kappa}10C is capable of recombination, as rearrangements are detected in both spleen and bone marrow of adult mice. The J{kappa} 5–3 primer used in the PCRs is located downstream of J{kappa}5; thus, the recombination products are in the context of the C{kappa} region and are not the result of secondary recombinations with displaced J{kappa} resulting from inversional recombinations of other V{kappa} genes. Since small amounts of V{kappa}10C mRNA are detectable in spleen, bone marrow, and fetal liver, some of the rearrangements may result in productive V-J joins, although it has been shown that nonproductive rearrangements can be transcribed at levels comparable with or even greater than productive rearrangements (38).

Analysis of 13 unique V{kappa}10C and 10 unique V{kappa}10A junctions revealed some interesting differences. Seven of the nine in-frame V{kappa}10C-J{kappa}1 junctions were missing the proline residue at position 95. This was not seen for any in-frame V{kappa}10A junctions. Proline 95 is invariant in murine {kappa}-chains and is present in all of the V{kappa}10A or V{kappa}10B sequences obtained from GenBank. It is possible that the loss of proline 95 results in light chains that cannot fold properly or pair effectively with heavy chains.

Finally, it is not known how overall chromatin configuration affects the expression of V{kappa} genes. LINE elements are commonly found in the V{kappa} and VH loci of mice (67, 68, 69). In some cases, LINEs have been involved in aberrant rearrangements of these genes (70). LINEs are transposable elements that contain two open reading frames, one of which codes for a reverse transcriptase (59), and recently, LINE proteins have been identified (71, 72). LINE elements are present at 104 copies per haploid genome, and many of these are truncated, usually at the 5' end (59). It has been shown that at least 25% of V{kappa} genes contain a common BamHI site 3' of the coding region (57). We have shown that this BamHI site is contributed by LINE elements. Both V{kappa}10A and V{kappa}10C contain LINE elements in this position, but only V{kappa}10A has the conserved BamHI site. We have not sequenced a V{kappa}10B gene to see whether there is a LINE element present, but, from published restriction maps (42), it does contain the conserved BamHI site. It is not known whether the truncation of the V{kappa}10C LINE affects the overall expression of this gene or interferes with proper recombination, resulting in a high frequency of V{kappa}10C rearrangements that lack the invariant proline 95.

Because the V{kappa}10C gene is structurally functional, the lack of hybridomas and myelomas utilizing V{kappa}10C suggests that V{kappa}10C-expressing cells are negatively selected. Alternatively, V{kappa}10C-rearranged cells may not be actively selected, either negatively or positively. Positive selection has been demonstrated for a specific VHCDR3 sequence to make the transition from a pre-BI cell to a pre-BII cell (73) and for certain VH-VL pairs to move immature cells from the bone marrow into the immunocompetent B cell pool in the periphery (8). Because V{kappa}10C rearrangements are detected in both the spleen and bone marrow and the V{kappa}10C promoter is inefficient in pre-B cells when {kappa} rearrangement begins, V{kappa}10C-rearranged cells may be unable to undergo selection. There may be a threshold of surface Ig expression for selection to occur. Inefficient V{kappa}10C transcription may not produce enough V{kappa}10C protein to reach this threshold. Similarly, an intrinsic defect in recombination of V{kappa}10C, resulting in proteins unable to pair efficiently with heavy chain, would have the same outcome. Because such cells are not selected, they can rearrange the other {kappa} allele, the {lambda} locus, or undergo receptor editing. Such cells would then have a chance to undergo positive or negative selection, but this selection would not be due to V{kappa}10C expression. Regardless of the reason for the underutilization of V{kappa}10C in the Ab repertoire, it is clear that not all structurally functional genes contribute to Ab diversity.


    Acknowledgments
 
We thank Drs. Fred Mushinski and Walter Gerhard for gifts of cell lines, Dr. Kevin Holmes and Larry Lantz for biotin-labeled ThB, and Drs. Stuart Rudikoff, Steve Bauer, and Mark Brunswick for critical review of the manuscript.


    Footnotes
 
1 Address correspondence and reprint requests to Dr. Marjorie Shapiro, Division of Monoclonal Antibodies, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Bldg. 29B, Room 5E12, Rockville, MD 20852. E-mail address: Back

2 Abbreviations used in this paper: RSS, recombination signal sequence; CDR, complementarity-determining region; TAE, 40 mM Tris-Cl, pH 7.8, 20 mM sodium acetate, 1 mM EDTA. Back

3 The V{kappa}10A and V{kappa}10B germline genes are the V{kappa}10.1b (AJ1) and V{kappa}10.2b (AJ2) genes characterized by Kim et al. (42) from A/J mice and the V{kappa}10 ars-a gene and V{kappa}10b gene characterized by Victor-Kobrin et al. (61) from BALB/c mice. Back

Received for publication October 16, 1997. Accepted for publication May 4, 1998.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Wu, G., R. Jaenichen, H. G. Zachau. 1996. The mouse immunoglobulin {kappa} locus contains about 140 variable gene segments. Eur. J. Immunol. 26:1613.[Medline]
  2. Brodeur, P. H., R. Riblet. 1984. The immunoglobulin heavy chain variable region (Igh-V) locus in the mouse. I. One hundred Igh-V genes comprise seven families of homologous genes. Eur. J. Immunol. 14:922.[Medline]
  3. Kofler, R., S. Geley, H. Kofler, A. Helmberg. 1992. Mouse variable-region gene families: complexity, polymorphism and use in non-autoimmune responses. Immunol. Rev. 128:5.[Medline]
  4. Stiernholm, N. B. J., N. L. Berinstein. 1995. A mutated promoter of a human Ig V{lambda} gene segment is associated with reduced germ-line transcription and a low frequency of rearrangement. J. Immunol. 154:1748.[Abstract]
  5. Schlissel, M. S., T. Morrow. 1994. Ig heavy chain protein controls B cell development by regulating germ-line transcription and retargeting V(D)J recombination. J. Immunol. 153:1645.[Abstract]
  6. Buchanan, K. L., S. I. Hodgetts, J. Byrnes, C. F. Webb. 1995. Differential transcription efficiency of two Ig VH promoters in vitro. J. Immunol. 155:4270.[Abstract]
  7. Goodnow, C. C., J. J. Cyster, S. B. Hartley, S. E. Bell, M. P. Cooke, J. I. Healy, S. Akkaraju, J. C. Rathmell, S. L. Pogue, K. P. Shokat. 1995. Self-tolerance checkpoints in B lymphocyte development. Adv. Immunol. 59:279.[Medline]
  8. Hachemi-Rachedi, S., A. Cumano, A.-M. Drapier, P.-A. Cazenave, P. Sanchez. 1997. Does positive selection determine the B cell repertoire?. Eur. J. Immunol. 27:1069.[Medline]
  9. Grandien, A., Y. Modigliani, A. Freitas, J. Andersson, A. Coutinho. 1994. Positive and negative selection of antibody repertoires during B cell differentiation. Immunol. Rev. 137:53.[Medline]
  10. Yancopoulos, G. D., S. V. Desiderio, M. Paskind, J. F. Kearney, D. Baltimore, F. W. Alt. 1984. Preferential utilization of the most JH-proximal VH gene segments in pre-B cell lines. Nature 311:727.[Medline]
  11. Perlmutter, R. M., J. F. Kearney, S. P. Chang, L. E. Hood. 1985. Developmentally controlled expression of VH genes. Science 227:1597.[Abstract/Free Full Text]
  12. Jeong, H. D., J. M. Teale. 1988. Comparison of the fetal and adult functional B cell repertoires by analysis of VH gene family expression. J. Exp. Med. 168:589.[Abstract/Free Full Text]
  13. Sheehan, K. M., C. A. Mainville, S. Willert, P. H. Brodeur. 1993. The utilization of individual VH exons in the primary repertoire of adult BALB/c mice. J. Immunol. 151:5364.[Abstract]
  14. Dildrop, R., U. Krawinkel, E. Winter, K. Rajewsky. 1985. VH-gene expression in murine lipopolysaccharide blasts distributes over the nine known VH-gene groups and may be random. Eur. J. Immunol. 15:1154.[Medline]
  15. Manser, T., S.-Y. Huang, M. L. Gefter. 1984. Influence of clonal selection on the expression of immunoglobulin variable region genes. Science 226:1283.[Abstract/Free Full Text]
  16. Schulze, D. H., G. Kelsoe. 1987. Genotypic analysis of B cell colonies by in situ hybridization: stoichiometric expression of three VH families in adult C57BL/6 and BALB/c mice. J. Exp. Med. 166:163.[Abstract/Free Full Text]
  17. Alt, F. W., T. K. Blackwell, G. D. Yancopoulos. 1987. Development of the primary antibody repertoire. Science 238:1079.[Abstract/Free Full Text]
  18. Yancopoulos, G. D., B. A. Malynn, F. W. Alt. 1988. Developmentally regulated and strain-specific expression of murine VH gene families. J. Exp. Med. 168:417.[Abstract/Free Full Text]
  19. Kaushik, A., D. H. Schulze, C. Bona, G. Kelsoe. 1989. Murine V{kappa} gene expression does not follow the VH paradigm. J. Exp. Med. 169:1859.[Abstract/Free Full Text]
  20. Teale, J. M., E. G. Morris. 1989. Comparison of V{kappa} gene family expression in adult and fetal B cells. J. Immunol. 143:2768.[Abstract]
  21. Lawler, A. M., J. F. Kearney, M. Kuehl, P. J. Gearhart. 1989. Early rearrangements of genes encoding murine immunoglobulin {kappa} chains, unlike genes encoding heavy chains, use variable gene segments dispersed throughout the locus. Proc. Natl. Acad. Sci. USA 86:6744.[Abstract/Free Full Text]
  22. Shapiro, M. A., M. Weigert. 1987. How immunoglobulin genes rearrange. J. Immunol. 139:3834.[Abstract]
  23. Medina, C. A., J. M. Teale. 1993. Restricted {kappa} chain expression in early ontogeny: biased utilization of V{kappa} exons and preferential V{kappa}-J{kappa} recombinations. J. Exp. Med. 177:1317.[Abstract/Free Full Text]
  24. Ramsden, D. A., C. J. Paige, G. E. Wu. 1994. {kappa} light chain rearrangement in mouse fetal liver. J. Immunol. 153:1150.[Abstract]
  25. Goodhardt, M., P. Cavelier, N. Doyen, S. Kallenbach, C. Babinet, F. Rougeon. 1993. Methylation status of immunoglobulin {kappa} gene segments correlates with their recombination potential. Eur. J. Immunol. 23:1789.[Medline]
  26. Hsieh, C.-L., M. R. Lieber. 1992. CpG methylated minichromosomes become inaccessible for V(D)J recombination after undergoing replication. EMBO J. 11:315.[Medline]
  27. Engler, P., D. Haasch, C. A. Pinkert, L. Doglio, M. Glymour, R. Brinster, U. Storb. 1991. A strain-specific modifier on mouse chromosome 4 controls the methylation of independent transgene loci. Cell 65:939.[Medline]
  28. Yancopoulos, G. D., F. W. Alt. 1985. Developmentally controlled and tissue-specific expression of unrearranged VH gene segments. Cell 40:271.[Medline]
  29. Blackwell, T. K., M. W. Moore, G. D. Yancopoulos, H. Suh, S. Lutzker, E. Selsing, F. W. Alt. 1986. Recombination between immunoglobulin variable region gene segments is enhanced by transcription. Nature 324:585.[Medline]
  30. Berman, J. E., C. G. Humphries, J. Barth, F. W. Alt, P. W. Tucker. 1991. Structure and expression of human germline VH transcripts. J. Exp. Med. 173:1529.[Abstract/Free Full Text]
  31. Schlissel, M. S., D. Baltimore. 1989. Activation of immunoglobulin {kappa} gene rearrangement correlates with induction of germline {kappa} gene transcription. Cell 58:1001.[Medline]
  32. Martin, D., R. Q. Huang, T. LeBien, B. Van Ness. 1991. Induced rearrangement of {kappa} genes in the BLIN-1 human pre-B cell line correlates with germline J-C{kappa} and V{kappa} transcription. J. Exp. Med. 173:639.[Abstract/Free Full Text]
  33. Ramsden, D. A., G. E. Wu. 1997. Mouse {kappa} light-chain recombination signal sequences mediate recombination more frequently than do those of {lambda} light chains. Proc. Natl. Acad. Sci. USA 88:10721.[Abstract/Free Full Text]
  34. Hesse, J. E., M. R. Lieber, K. Mizuuchi, M. Gellert. 1989. V(D)J recombination: a functional definition of the joining signals. Genes Dev. 3:1053.[Abstract/Free Full Text]
  35. Buchanan, K. L., E. A. Smith, S. Dou, L. M. Corcoran, C. F. Webb. 1997. Family-specific differences in transcription efficiency of Ig heavy chain promoters. J. Immunol. 159:1247.[Abstract]
  36. Strohal, R., A. Helmberg, G. Kroemer, R. Kofler. 1989. Mouse V{kappa} gene classification by nucleic acid sequence similarity. Immunogenetics 30:475.[Medline]
  37. Sanz, I., J. D. Capra. 1987. V{kappa} and J{kappa} gene segments of A/J Ars-A antibodies: somatic recombination generates the essential arginine at the junction of the variable and joining regions. Proc. Natl. Acad. Sci. USA 84:1085.[Abstract/Free Full Text]
  38. Kelley, D. E., L. M. Wiedemann, A. C. Pittet, S. Strauss, K. J. Nelson, J. Davis, B. Van Ness, R. P. Perry. 1985. Nonproductive {kappa} immunoglobulin genes: recombinational abnormalities and other lesions affecting transcription, RNA processing, turnover, and translation. Mol. Cell. Biol. 5:1660.[Abstract/Free Full Text]
  39. Boswell, C. M., D. C. Irwin, J. Goodnight, K. E. Stein. 1992. Strain-dependent restricted VH and VL usage by anti-bacterial levan monoclonal antibodies. J. Immunol. 148:3864.[Abstract]
  40. Kavaler, J., A. J. Caton, L. M. Staudt, D. Schwartz, W. Gerhard. 1990. A set of closely related antibodies dominates the primary antibody response to the antigenic site Cb of the A/PR/8/34 influenza virus hemagglutinin. J. Immunol. 145:2312.[Abstract]
  41. Pennycook, J., A. J. Marshall, G. E. Wu. 1997. PCR assays for endogenous Ig gene rearrangement. I. Lefkovits, ed. Immunology Methods Manual 250. Academic Press, New York.
  42. Kim, S.-O., I. Sanz, C. Williams, J. D. Capra, P. D. Gottlieb. 1991. Polymorphism in V{kappa}10 genes encoding L chains of antibodies bearing the Ars-A and A48 cross-reactive idiotypes. Immunogenetics 34:231.[Medline]
  43. Kalled, S., P. H. Brodeur. 1991. Utilization of V{kappa} families and V{kappa} exons. J. Immunol. 147:3194.[Abstract]
  44. Falkner, F. G., H. G. Zachau. 1984. Correct transcription of an immunoglobulin {kappa} gene requires an upstream fragment containing conserved sequence elements. Nature 310:71.[Medline]
  45. Parslow, T. G., D. L. Blair, W. J. Murphy, D. K. Granner. 1984. Structure of the 5' ends of immunoglobulin genes: a novel conserved sequence. Proc. Natl. Acad. Sci. USA 81:2650.[Abstract/Free Full Text]
  46. Queen, C., J. Foster, C. Stauber, J. Stafford. 1986. Cell-type specific regulation of a {kappa} immunoglobulin gene by promoter and enhancer elements. Immunol. Rev. 89:49.[Medline]
  47. Wirth, T., L. Staudt, D. Baltimore. 1987. An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity. Nature 329:174.[Medline]
  48. Atchison, M. A., V. Delmas, R. P. Perry. 1990. A novel upstream element compensates for an ineffectual octamer motif in an immunoglobulin V{kappa} promoter. EMBO J. 9:3109.[Medline]
  49. Ephrussi, A., G. M. Church, S. Tonegawa, W. Gilbert. 1985. B lineage-specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science 227:134.[Abstract/Free Full Text]
  50. Hogbom, E., A.-C. Magnusson, T. Leanderson. 1991. E-boxes as promoter elements in B cell lines and untransformed B lymphocytes. Scand. J. Immunol. 33:615.[Medline]
  51. Siden, E. J., D. Baltimore, D. Clark, N. E. Rosenberg. 1979. Immunoglobulin synthesis by lymphoid cells transformed in vitro by Abelson murine leukemia virus. Cell 16:389.[Medline]
  52. Nelson, K. J., E. L. Mather, R. P. Perry. 1984. Lipopolysaccharide-induced transcription of the {kappa} immunoglobulin locus occurs on both alleles and is independent of methylation status. Nucleic Acids Res. 12:1911.[Abstract/Free Full Text]
  53. Hardy, R. R., J. L. Dangl, K. Hayakawa, G. Jager, L. A. Herzenberg. 1986. Frequent {lambda} light chain gene rearrangement and expression in a Ly-1 B lymphoma with a productive {kappa} chain allele. Proc. Natl. Acad. Sci. USA 83:1438.[Abstract/Free Full Text]
  54. Kleinfeld, R., R. R. Hardy, D. Tarlinton, J. Dangl, L. A. Herzenberg, M. Weigert. 1986. Recombination between an expressed immunoglobulin heavy-chain gene and a germline variable gene segment in a Ly 1+ B cell lymphoma. Nature 322:843.[Medline]
  55. Eckhardt, L. A., L. A. Herzenberg. 1980. Monoclonal antibodies to ThB detect close linkage of Ly-6 and a gene regulating ThB expression. Immunogenetics 11:275.[Medline]
  56. Coffman, R. L.. 1998. Surface antigen expression and immunoglobulin gene rearrangement during mouse pre-B cell development. Immunol. Rev. 69:5.
  57. Clarke, S., S. McCray. 1991. A shared {kappa} reciprocal fragment and a high frequency of secondary J{kappa}5 rearrangements among influenza hemagglutinin specific B cell hybridomas. J. Immunol. 146:343.[Abstract]
  58. Kalled, S. L., P. H. Brodeur. 1990. Preferential rearrangement of V{kappa}4 gene segments in pre-B cell lines. J. Exp. Med. 172:559.[Abstract/Free Full Text]
  59. III. Hutchison, C. A., S. C. Hardies, D. D. Loeb, W. R. Shehee, M. H. Edgell. 1989. LINEs and related retrotransposons: long interspersed repeated sequences in the eukaryotic genome. D. E. Berg, and M. M. Howe, eds. Mobile DNA 593.-617. American Society for Microbiology, Washington, DC.
  60. Sollbach, A., A. Marshall, C. Yu, J. Pennycook, G. E. Wu. 1994. Understanding patterns of immunoglobulin gene rearrangements. Semin. Immunol. 6:197.[Medline]
  61. Victor-Kobrin, C., Z. T. Barak, F. A. Bonilla, B. Kobrin, I. Sanz, D. French, J. Rothe, C. Bona. 1990. A molecular and structural analysis of the VH and V{kappa} regions of monoclonal antibodies bearing the A48 regulatory idiotype. J. Immunol. 144:614.[Abstract]
  62. Marion, T. N., D. M. Tillman, N.-T. Jou. 1990. Interclonal and intraclonal diversity among anti-DNA antibodies from an (NZB x NZW)F-1 mouse. J. Immunol. 145:2322.[Abstract]
  63. Kabat, E. A., T. T. Wu, M. Reid-Miller, H. M. Perry, and K. S. Gottesman. 1987. Sequences of Proteins of Immunological Interest. U.S. Department of Public Health and Human Services, National Institutes of Health, Bethesda, MD.
  64. Bentley, D. L., T. H. Rabbits. 1980. Human immunoglobulin variable region genes: DNA sequences of two V {kappa} genes and a pseudogene. Nature 288:730.[Medline]
  65. Baumruker, T., R. Sturm, W. Herr. 1988. OBP100 binds remarkably degenerated octamer motifs through specific interactions with flanking sequences. Genes Dev. 2:1400.[Abstract/Free Full Text]
  66. Sigvardsson, M., T. Leanderson. 1994. Positive transcriptional control elements within the SP6 {kappa} promoter decamer 3' flanking sequence. Mol. Immunol. 31:1005.[Medline]
  67. Wilson, R., U. Storb. 1983. Association of two different repetitive DNA elements near immunoglobulin light chain genes. Nucleic Acids Res. 11:1803.[Abstract/Free Full Text]
  68. Gebhard, W., T. Meitinger, J. Hochtl, H. G. Zachau. 1982. A new family of interspersed repetitive DNA sequences in the mouse genome. J. Mol. Biol. 157:453.[Medline]
  69. Gebhard, W., H. G. Zachau. 1983. Organization of the R family and other interspersed repetitive DNA sequences in the mouse genome. J. Mol. Biol. 170:255.[Medline]
  70. Bard, J. A., B. K. Birshtein. 1995. Rearrangement of a VH-associated LINE-1 element with the expressed IgH cluster in a murine myeloma cell line. J. Immunol. 154:201.[Abstract]
  71. Martin, S. L., D. Branciforte. 1993. Synchronous expression of LINE-1 RNA and protein in mouse embryonal carcinoma cells. Mol. Cell. Biol. 13:5383.[Abstract/Free Full Text]
  72. Leibold, D. M., G. D. Swergold, M. F. Singer, R. E. Thayer, B. A. Dombrowski, T. G. Fanning. 1990. Translation of LINE-1 DNA elements in vitro and in human cells. Proc. Natl. Acad. Sci. USA 87:6990.[Abstract/Free Full Text]
  73. Ye, J., S. K. McCray, S. H. Clarke. 1996. The transition of pre-BI to pre-BII cells is dependent on the VH structure of the µ/surrogate L chain receptor. EMBO J. 15:1524.[Medline]



This article has been cited by other articles:


Home page
J. Immunol.Home page
S. P. Fitzsimmons, K. J. Clark, H. S. Mostowski, and M. A. Shapiro
Underutilization of the V{kappa}10C Gene in the B Cell Repertoire Is Due to the Loss of Productive VJ Rearrangements During B Cell Development
J. Immunol., July 15, 2000; 165(2): 852 - 859.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Li, R. E. Hammer, J. B. George-Raizen, K. C. Meyers, and W. T. Garrard
High-Level Rearrangement and Transcription of Yeast Artificial Chromosome-Based Mouse Ig{kappa} Transgenes Containing Distal Regions of the Contig
J. Immunol., January 15, 2000; 164(2): 812 - 824.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fitzsimmons, S. P.
Right arrow Articles by Shapiro, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fitzsimmons, S. P.
Right arrow Articles by Shapiro, M. A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS